Flow cytometry revealed that the number of CD11b+ F4/80+ macrophages in R428-treated ICC samples was comparable to that of controls (Supplemental Figure 7, L and M, and Supplemental Figure 14A). The gene discussed is ITGAM; the disease is intrahepatic cholangiocarcinoma.